Yong-Soo Kwon
Overview
Explore the profile of Yong-Soo Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park H, Oh H, Park H, Yoon J, Yoon C, Kho B, et al.
Tuberc Respir Dis (Seoul)
. 2025 Feb;
PMID: 39933718
Background: Small cell lung cancer (SCLC) is called 'smoker's disease' because it is strongly associated with smoking and most cases occur in smokers. However, it can also occur in never...
2.
Kim S, Silvestri G, Kim Y, Kim R, Um S, Im Y, et al.
J Thorac Oncol
. 2024 Dec;
PMID: 39662732
Introduction: Guideline-discordant low-dose computed tomography (LDCT) screening may cause lung cancer (LC) overdiagnosis, but its extent and consequences are unclear. This study aimed to investigate the prevalence of self-initiated, non-reimbursed...
3.
Yoon C, Park H, Lee J, Kho B, Kim T, Shin H, et al.
Chonnam Med J
. 2024 Oct;
60(3):166-173.
PMID: 39381118
COVID-19 can lead to pulmonary complications, including organizing pneumonia. Steroids are essential in treating post-COVID-19 organizing pneumonia. However, research on the clinical benefits of initiating steroid treatment early for this...
4.
Kwak N, Kim J, Kim H, Kwon B, Lee J, Mok J, et al.
Tuberc Respir Dis (Seoul)
. 2024 Sep;
88(1):170-180.
PMID: 39343425
Background: This study aimed to determine whether a shorter high-dose rifampicin regimen is non-inferior to the standard 6-month tuberculosis regimen. Methods: This multicenter, randomized, open-label, non-inferiority trial enrolled participants with...
5.
Yoon J, Kim T, Kim J, Kim H, Lee E, Jung S, et al.
PLoS One
. 2024 Sep;
19(9):e0309902.
PMID: 39325726
Background: Pyrazinamide (PZA) usage has been associated with adverse drug reactions, prompting its avoidance in treating elderly tuberculosis (TB) patients. This study aims to examine whether the administration of PZA...
6.
Lee J, Kho B, Yoon J, Yoon C, Na Y, Park H, et al.
J Thorac Dis
. 2024 Sep;
16(8):4924-4934.
PMID: 39268104
Background: A pulmonary artery-to-aorta (PA/A) ratio of ≥1 is a reliable indicator of pulmonary hypertension and is associated with an increased risk of acute exacerbation of chronic obstructive pulmonary disease...
7.
Won E, Lee Y, Kim M, Kim T, Shin H, Kim T, et al.
PLoS One
. 2024 Aug;
19(8):e0309446.
PMID: 39196906
Although gastroesophageal reflux has been recognized as one of the risk factors of nontuberculous mycobacterial pulmonary disease (NTM-PD) progression, the effect of reflux on the lower respiratory tract microbiota has...
8.
Kim J, Kho B, Yoon C, Na Y, Lee J, Park H, et al.
Medicine (Baltimore)
. 2024 Jun;
103(26):e38644.
PMID: 38941408
Few studies have examined the risk factors associated with the type of acute respiratory failure (ARF) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). This study evaluated...
9.
Kwak N, Henkle E, Hwang H, Jeon D, Jhun B, Jo K, et al.
Clin Infect Dis
. 2024 Apr;
78(6):1690-1697.
PMID: 38563246
Background: Improving health-related quality of life (HRQOL) has emerged as a priority in the management of nontuberculous mycobacterial pulmonary disease (NTM-PD). We aimed to evaluate HRQOL and its changes after...
10.
Yasir M, Park J, Lee Y, Han E, Park W, Han J, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069313
γ-Aminobutyric acid aminotransferase (GABA-AT) is a pyridoxal 5'-phosphate (PLP)-dependent enzyme that degrades γ-aminobutyric (GABA) in the brain. GABA is an important inhibitory neurotransmitter that plays important neurological roles in the...